Research by Kawakami-Tani shows that concomitant administration (such as thyroid hormones or anti-thyroid drugs) of 1α(OH)D3 is useful for treating hyperthyroidism in patients with Graves’ disease [51]. This evidence concerns the gene TG and hyperthyroidism.